Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Lumos Pharma
Lumos Pharma
Actuate Therapeutics Inc.
iOnctura
Verastem, Inc.
OHSU Knight Cancer Institute
Ludwig-Maximilians - University of Munich
Brown University
H. Lee Moffitt Cancer Center and Research Institute
Theriva Biologics SL
Mereo BioPharma
Halozyme Therapeutics
Universitaire Ziekenhuizen KU Leuven
Stamford Hospital
Incyte Corporation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
GERCOR - Multidisciplinary Oncology Cooperative Group
University of California, San Francisco